Bolder biotech investments, not less, is key to better health outcomes for all
The goal is expanding access to drugs and the types of patients that can benefit from treatments.
HEALTHCARE costs are rising globally. This is driven by ageing populations, lifestyle demographic shifts, newer treatments being offered, and a skilled manpower shortage.
Since the Covid-19 pandemic, inflationary pressures have been experienced across the healthcare industry. The WTW Global Medical Trends Survey projects more than 10 per cent increase in medical costs in 2025.
Yet, evidence of an association between healthcare costs and quality outcomes is inconsistent.
TRENDING NOW
On the board but frozen out: The Taib family feud tearing Sarawak construction giant apart
Thai and Vietnamese farmers may stop planting rice because of the Iran war. Here’s why
PayPal plans job cuts as its new CEO pursues turnaround strategy
MAS, bank CEOs convene over AI cyberthreats; boards told to own risks, not leave to IT teams